Peiliang Zhang holds a Ph.D. in Traditional Chinese Medicine from Shanghai University of Traditional Chinese Medicine (2021), one of China’s leading institutions in the field. His doctoral research focused on natural product drug discovery and analytical chemistry, particularly investigating bioactive compounds in traditional Chinese medicine (TCM). Throughout his academic journey, he has gained expertise in mass spectrometry (MS), nuclear magnetic resonance (NMR), and other advanced analytical techniques essential for identifying and characterizing medicinal compounds. His education provided a strong foundation in pharmacognosy, herbal medicine, and quality evaluation of TCM, enabling him to develop innovative methods for rapid bioactive compound identification. Currently, he applies his academic knowledge as a Research Scientist at Shanghai University of Chinese Medicine, contributing to cutting-edge research in TCM standardization and industrial applications. His education has been instrumental in shaping his career as a researcher dedicated to advancing the field of natural medicine chemistry.

Peiliang Zhang is a dedicated researcher specializing in traditional Chinese medicine (TCM) and natural product chemistry. He earned his Ph.D. from Shanghai University of Traditional Chinese Medicine in 2021 and currently serves as a Research Scientist at Shanghai University of Chinese Medicine. His expertise lies in the identification and analysis of bioactive compounds from medicinal plants, with a particular focus on Dendrobium species. Proficient in advanced analytical techniques such as mass spectrometry (MS) and nuclear magnetic resonance (NMR), he has contributed significantly to developing innovative methods for rapid compound identification. Zhang has completed or is actively involved in 10 research projects, publishing multiple SCI-indexed papers in high-impact journals. His pioneering work on EFISI-MS in-situ mass spectrometry technology has improved the efficiency of TCM compound characterization. With a growing citation index and an expanding research portfolio, he is committed to advancing the field of TCM through innovation and scientific rigor.

Peiliang Zhang’s research interests lie at the intersection of traditional Chinese medicine (TCM), analytical chemistry, and natural medicine chemistry, with a strong focus on natural product drug discovery and development. His work primarily explores the bioactive components of medicinal plants, particularly the Dendrobium species and Nelumbo nucifera. He specializes in advanced analytical techniques such as mass spectrometry (MS) and nuclear magnetic resonance (NMR) to identify and characterize bioactive compounds. A key aspect of his research is the development of EFISI-MS in-situ mass spectrometry technology, which enhances the efficiency of bioactive compound identification by reducing complex sample preparation. His studies aim to improve the standardization, quality control, and industrial application of TCM, bridging the gap between traditional herbal medicine and modern pharmaceutical sciences. Through his innovative methodologies, Zhang contributes to the rapid and accurate identification of therapeutic compounds, supporting advancements in natural medicine research and drug development.

Peiliang Zhang has made significant contributions to the field of traditional Chinese medicine (TCM) through his innovative research on bioactive compounds and analytical chemistry. As a dedicated Research Scientist at Shanghai University of Chinese Medicine, he has successfully completed ten research projects and published multiple high-impact, SCI-indexed journal articles. His groundbreaking work on EFISI-MS in-situ mass spectrometry technology has introduced novel methods for rapid and efficient identification of active compounds in TCM. His research has been recognized through citations and contributions to leading scientific journals such as Talanta and Journal of Natural Products. While he has not yet received major international awards, his academic excellence and research achievements position him as a promising candidate for prestigious honors in the future. His dedication to advancing TCM standardization and industrial applications continues to shape the field, and his work holds immense potential for global recognition in medicinal research.

Peiliang Zhang is a dedicated and accomplished researcher specializing in traditional Chinese medicine, analytical chemistry, and natural medicine chemistry. His contributions, particularly in developing EFISI-MS in-situ mass spectrometry technology, have significantly advanced the identification of bioactive compounds, addressing inefficiencies in current research methodologies. With multiple SCI-indexed publications in high-impact journals and ten completed or ongoing research projects, he demonstrates a strong research foundation. However, the absence of patents, industry collaborations, and professional memberships slightly limits his profile in terms of broader research influence and innovation commercialization. Despite these areas for improvement, his work has substantial academic value and contributes to the industrial advancement of traditional Chinese medicine. His strong publication record and innovative research methods make him a worthy candidate for the Best Researcher Award, though strengthening his engagement in patents, industry projects, and professional networks would further enhance his research impact and overall competitiveness for such recognitions.